June 2026 update: FDA issues 25 more warning letters to telehealth companies During the week of June 15, 2026 - days before this article was published - the FDA issued 25 additional warning letters to telehealth companies over false or misleading promotional claims about compounded GLP-1 products
Before the infusion begins, a brief health screening confirms candidacy, reviews current medications and any contraindications, and identifies customization preferences such as additional wellness boosters or adjusted dosages
Liu L, Li X, Chen Y, Gao J, Jiang Y, Ye Y, et al
Mechanisms of insulin action
Many of our patients are losing 10 pounds a month